Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Brown

Ophthalmology West Des Moines, IA Medical Doctor

NPI 1427018423 CMS profile 337260

2101 Westown Pkwy, West Des Moines, IA 50265

Open in the dashboard

General payments

$2,676

101 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Brown of West Des Moines, IA is reported in the CMS Open Payments database as having received $2,676 across 101 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $542 23
2024 General $646 22
2023 General $440 16
2022 General $500 14
2021 General $110 7
2020 General $154 9
2019 General $285 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Brown
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Elizabeth Brown were reported at $542. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Elizabeth Brown Ophthalmology median Middle half National median
2019 $285 $258 $104–$655 $163
2020 $154 $126 $45–$321 $114
2021 $110 $205 $76–$534 $132
2022 $500 $266 $100–$678 $149
2023 $440 $308 $117–$745 $160
2024 $646 $340 $127–$846 $164
2025 $542 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $612 20 payments
  2. Bausch & Lomb Americas Inc. $349 11 payments
  3. Alcon Vision LLC $296 16 payments
  4. Allergan Inc. $199 9 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $194 6 payments
  6. Tarsus Pharmaceuticals, Inc. $173 6 payments
  7. Oyster Point Pharma, Inc. $144 6 payments
  8. TissueTech, Inc. $108 2 payments
  9. Sight Sciences, Inc. $100 1 payment
  10. Dompe US, Inc. $90 3 payments
  11. Other $410 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,676 101 payments
Products named General payments · program years 2019–2025
  1. LUMIGAN Eye Care $416 16 payments
  2. VYZULTA $232 11 payments
  3. MIEBO $231 7 payments
  4. XDEMVY $173 6 payments
  5. LOTEMAX SM $164 4 payments
  6. DURYSTA $155 2 payments
  7. LUMIGAN Ophthalmology $142 4 payments
  8. COMBIGAN $142 3 payments
  9. PROKERA $108 2 payments
  10. AMNIOGRAFT $108 2 payments
  11. Other $1,530 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

1,630

Median for Ophthalmology: 891

Drug cost

$160,540

Median for Ophthalmology: $68,233

Branded share of claims

32.8%

Median for Ophthalmology: 29.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lumigan Bimatoprost Brand 137 $67,138
Restasis Cyclosporine Brand 31 $26,199
Rhopressa Netarsudil Mesylate Brand 45 $13,785
Combigan Brimonidine Tartrate/Timolol Brand 30 $8,219
Vyzulta Latanoprostene Bunod Brand 18 $7,912
Brimonidine Tartrate Generic 80 $7,225
Alphagan P Brimonidine Tartrate Brand 19 $5,364
Simbrinza Brinzolamide/Brimonidine Tart Brand 23 $4,552
Latanoprost Generic 523 $3,403
Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol Brand 29 $3,294

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,260 Part D prescribers listed as Ophthalmology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$190,039

Medicare's payments for the services billed

Medicare patients

914

Average age 78

Services billed

3,703

607 women, 307 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 41%
Chronic kidney disease 23%
Osteoporosis 22%
Diabetes 20%
Ischemic heart disease 19%
Depression 19%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LUMIGAN
  • AbbVie, Inc. $226
$226 137 —
DURYSTA
  • AbbVie, Inc. $155
$155 — —
XDEMVY
  • Tarsus Pharmaceuticals, Inc. $127
$127 — —
TYRVAYA
  • Oyster Point Pharma, Inc. $44
$44 — —
TEPEZZA
  • Amgen Inc. $27
$27 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

101 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record